SlideShare a Scribd company logo
Perioperative management and
Fluid
Neda Amini, MD
Northwell health
Surgical oncology Fellow
BODY WATER DISTRIBUTION
 Percent Of Body Weight
–Male: 55 – 60%
–Female: 50 – 55%
 Fluid Compartments
 intracellular volume : 2/3 of Body Water
 extracellular volume: 1/3 of Body Water
 Plasma: 25% of ECF
 Interstitial Fluid: 75% of ECF
 healthy 70-kg male predicted to have a TBW content of
42 L (60% of total body weight). The intracellular volume
is 28 L (two-thirds TBW) and the extracellular volume 14
L (one-third TBW)>>3.5 L plasma
 balance of TBW is directed by a complex interaction
between membranes and solutes
 Membranes separating intracellular and extracellular
compartments are freely permeable to water, such that
the osmolality of the intracellular, interstitial, and
intravascular compartments remains equal.
Albumin represents the most important osmotically active constituent of the ECV and is virtually excluded from the ICV.
Albumin is unequally distributed within the ECV; the serum concentration of albumin approximates 4.0g/dl, while the IF
concentration averages 1.0g/dl.
Capillary membranes are freely permeable to most small solutes (less than 50,000 kDA), including sodium, potassium, glucose,
and low-molecular-weight proteins.
They have the ability to create osmotic forces that direct the movement of water across a membrane. Water moves across
membranes via intercellular junctions or transcellular routes
These nonpermeable solutes are known as effective osmoles.
 Movement of water across
capillary membranes is directed
by competing forces known as
Starling’s law.
 Starling’s law states that net
filtration is the difference
between the hydrostatic and
oncotic pressures of both the
interstitial and the capillary
fluids.
 Although small solutes do not contribute to water movement across capillary membranes, they do
function as effective osmoles that direct water movement between the intracellular and
extracellular spaces across cell membranes.
 Sodium (Na+) : potassium (K+) are the principal determinants of extracellular osmolarity
 potassium (K+) are the principal determinants of intracellular osmolality
 Na+ and K+ are unable to passively diffuse across the lipid-rich membrane with a gradient
generated and maintained by the Na+/K+ adenosine triphosphatase (ATPase) pump mechanism.
 Manipulation of either of these ions results in water movement from lower to higher osmolality
compartment in order to reestablish equilibrium.
 For example, administration of hypotonic solution (e.g.,
0.45% NaCl solution) results in decreased extracellular
osmolality, so water moves from the extracellular space
to the intracellular space, resulting in cellular swelling.
 In contrast, administration of a hypertonic solution (e.g.,
3% NaCl solution) results in increased extracellular
osmolality, so water moves from the intracellular space
to the extracellular space, resulting in cellular
dehydration.
Serum
Osmolality
 Measure of solute (osmoles) per
KG of water
 –Only accounts for solute which
contributes to the solution’s
osmotic pressure
 Serum Osmolality–Formula:(2 X
[Na]) + [Glucose]/18 + [BUN]/2.8
 Normal: 278 – 300 mOsm/kg
 Elevations in plasma osmolality result in stimulation of thirst along with
antidiuretic hormone (ADH) secretion from the posterior pituitary gland.
 ADH release results in upregulation of aquaporin channels in the basolateral
membrane of distal collecting tubules in the kidney, promoting free water
resorption down an established gradient. As a result of increased aquaporin
insertion, urine osmolality increases, with variations from 100 to 1200 mOsm/kg
depending on the serum osmolality.
 ADH secretion is also triggered by central baroreceptors that detect decreased
plasma volume. The result of ADH secretion is free water reabsorption in the
body’s attempt to restore normal osmolality and maintain homeostasis.
 The renin-angiotensin-aldosterone (RAA) axis promotes volume expansion.
Renin is secreted by the juxtaglomerular cells in response to renal
hypoperfusion or low sodium concentration in the macula densa region of the
distal tubule.
 Renin secretion promotes formation of angiotensin from angiotensinogen and
the eventual production of aldosterone, which promotes sodium reabsorption.
 atrial natriuretic peptide (ANP) results in net diuresis. ANP is a systemic
hormone released in response to cardiac atrial stretch and results in increased
renal blood flow through dilation of the afferent glomerular arteriole and
inhibition of sodium reabsorption in the kidney.
Assessment of Fluid Status
 In the immediate postoperative period, patients may have fluid deficits resulting
from preoperative or intraoperative fluid losses. Continued fluid losses in the
extended postoperative period from urine, skin, and the gastrointestinal (GI) tract
are common.
 It should be recognized that intravenous (IV) fluids are a therapy capable of
providing benefit when utilized appropriately but also able to cause harm when used
inappropriately.
 Commonly seen in the postoperative period, inflammatory states result in a low
effective intravascular volume despite an overall positive fluid balance due to
cytokine-induced permeability, which increases extracellular volume.
 Common signs and symptoms of low effective circulatory volume include abnormal
mentation, excessive thirst, dry mucous membranes, poor skin turgor, tachycardia,
hypotension, orthostatic changes in vital signs, and oliguria.
 Daily weights
 serum and urine electrolyte levels
 acid-base balance
 invasive monitoring
 Urine output is an excellent measure of volume status; adults should produce at
least 0.5 mL/kg/hr, whereas children should produce nearly 1 to 2 mL/kg/hr.
 However, in the setting of renal insufficiency, those receiving diuretics, or those
in hyperglycemic states, urine output may be an inaccurate measure of volume
status and resuscitation.
Additional indicators of intravascular depletion:
elevated hematocrit
low serum bicarbonate level with a base deficit
blood urea nitrogen/creatinine ratio greater than
20:1 (prerenal azotemia)
fractional excretion of sodium (FENa) of less than 1%.
 Elevated urine osmolality may suggest intravascular hypovolemia, but in the
setting of renal insufficiency or use of diuretics it is often an inaccurate
measure. The equation for fractional excretion of sodium is as follows:
Maintenance Fluids and Daily Electrolyte
Requirements
 Sensible losses can be quantified and occur primarily in urine (∼800 to 1500 mL
daily) and stool (∼250 mL daily).
 Insensible losses are unable to be quantified and include cutaneous losses from the
skin (75%) and upper respiratory tract (25%). Insensible losses often are quantified
roughly at 8 to 12 mL/kg per day.
 Sensible and insensible losses vary greatly in different physiologic states and
pathologic conditions, including fever, hyperventilation, burns, tachycardia, and
other hypermetabolic states.
 Cutaneous insensible losses increase by 10% per day for each 1°C increase in body
temperature above 37.1°C. Laparotomy and thoracotomy increase insensible
losses from the operative site at rates that approach nearly 1 L/hr.
 Daily maintenance fluid administration in both pediatric and adult populations can be calculated for a
24-hour period utilizing the 100-50-20 rule or hourly utilizing the 4-2-1 rule
 By definition, maintenance fluids contain dextrose. Their electrolyte composition is variable and
allows for replacement of these lost from insensible and sensible losses but these levels should be
closely monitored in postoperative patients.
 In general, the most common postoperative maintenance fluid for adults consists of 5% dextrose in
one-half normal saline (D5 1⁄2NS) with 20 mEq/L KCl.

 In children the standard maintenance fluid is D5 1⁄2NS or D5 lactated Ringer’s
solution (LR). This is to avoid hyponatremia, which has been shown to be of
critical importance in the pediatric population.
 Children younger than 2 years usually receive D5 1⁄4NS, with 20 mEq/L. The
reason for this is that until age 2 years, the kidney has a glomerular filtration rate
(GFR) that is one-quarter the adult level, and the distal nephrons are unable to
effectively concentrate the urine, leading to a difficulty in excreting high sodium
loads.
GI SECRETIONS
 When administering maintenance fluids, utilizing a 4-2-1 dosing regimen in a
70-kg male (110 mL/hr) results in a total sodium load of 203 mEq in a 24-hour
period, which is greater than the required 1 to 2 mEq/kg/day.
 Although patients with normal kidney function are able to excrete the excess
sodium load, caution should be utilized in patients with underlying renal
dysfunction, cardiac failure, or other serious comorbidities to not cause
iatrogenic hypernatremia.
 In general, maintenance fluids should be reassessed at least daily to ensure
that correct electrolyte and fluid volume needs are met but not exceeded.
Resuscitative
Fluids
 Resuscitative fluids are most commonly used the
immediate postoperative period, after injury, and in
the setting of hypotension.
 The rate of fluid administration is determined by the
severity of the existing deficit, presence of ongoing
losses, and the patient’s comorbidities.
 NS and LR closely approximate the composition of
extracellular fluid and therefore are the most
commonly used resuscitative fluids.
 LR has a pH of 6.5 and provides 28 mEq of bicarbonate
(HCO3 −) per liter, making it preferential in the setting
of acidosis.
 NS, at a pH of 4.5, does not contain HCO3 − but has a
greater concentration of Na+ and Cl− (154 mEq),
making it preferential in patients with a metabolic
alkalosis.
 However, it can create hyperchloremic metabolic
acidosis in the setting of high volume resuscitation.
 Severe fluid losses resulting in hemodynamic instability should be replaced
with isotonic resuscitative fluid boluses of 0.9% sodium chloride (NS solution)
or LR solution at volumes of 10 to 20 mL/kg, with boluses repeated until
adequate resuscitation is reached.
 Colloid solutions, such as 5% albumin, theoretically provide an advantage
when restoring intravascular volume because of the oncotic pressure afforded
by the protein content. However, liberal use of colloid solutions is less cost
effective and has not demonstrated improved patient outcomes in
randomized studies.
Sydney Ringer, credited for the
development of lactated Ringer
solution.
In 1883, Sydney Ringer reported
influence exerted by the
the blood on the contractions of
ventricle
Perioperative Care Management Domains
 Smoking Cessation
▪ urge all patients to quit smoking prior to surgery
 Smoking cessation intervention for all smokers, ideally ≥6 weeks before
surgery
Frailty
 describe generalized poor functional status and reduced physiologic reserve
that results in increased vulnerability to adverse outcomes.
 Frailty should be evaluated before considering major elective surgery.
Common clinical assessments include questionnaires such as the Modified
Frailty Index (MFI) and Clinical Frailty Scale (CFS)
 6-minute walking distance (6MWD) or hand-grip strength test.
 Improvement in these objective measurements over time has been shown to
improve outcomes.
Nutritional Status
 Balanced diet for all surgical patients
 Preoperative screening for malnutrition to allow for referral to dietitian and
immediate intervention if screening positive
MEDICATION MANAGEMENT
 Take morning of surgery:
 b-Blocker
 Asthmatic medications
 GERD medications
 Statins
 Aspirin (for CV surgery)
 ACE Inhibitors (if for Heart Failure & BP adequate)
 Calcium Channel Blocker–Alpha 2 Agonists
ORAL HYPOGLYCEMIC AGENTS
 Hold the morning of surgery
 Metformin Exception: Stop 24 hrs prior to procedures with contrast dye
 Major Surgery: Reports of lactic acidosis (when taken postoperatively
 Minor Surgery: No studies
INSULIN
 Hold morning dose of short/rapid-acting Insulin
 Reduce long-acting agents by half when taken night prior
 Assess blood glucose at hospital in AM
ACE INHIBITORS
 Discontinue night before surgery
 Exception: CHF patients
 Issues–Suppresses renin-angiotensin pathway–Hypotension unresponsive to
normal pressorswith general anesthesia induction
ANTICOAGULANTS
 Discontinuation varies with drug–Warfarin: 5 days
 Clopidogrel: 7 days
 Enoxaparin: 12 – 24 hours
Cardiac Stents
 Elective Noncardiac Surgery–
 Defer 12 months if possible
 Can’t wait –BMS – 30 days
 DES – 6 months–Discontinue clopidogrel 7 days prior–Continue Aspirin through
perioperative period(except neurosurgery and retinal surgery)
Questions
 neda2466@gmail.com
 Namini@northwell.edu

More Related Content

Similar to afghan med lec fluid.pptx

Fluid Therapy in Pediatrics
Fluid Therapy in PediatricsFluid Therapy in Pediatrics
Fluid Therapy in Pediatrics
Ravi Kumar
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
Zaheen Zehra
 
Postoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptxPostoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptx
AymanTaslima
 
FLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptxFLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptx
FLOWERSOFPAKISTAN
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balance
Diwakar vasudev
 
Fluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptxFluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptx
hrowshan
 
electrolytes mbbs class 2024 new.pptx ppt
electrolytes mbbs class 2024 new.pptx pptelectrolytes mbbs class 2024 new.pptx ppt
electrolytes mbbs class 2024 new.pptx ppt
dinesh kumar
 
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptxFLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
AmjadSayeed
 
Perioperative electrolyte disorder mgt1.
Perioperative electrolyte disorder mgt1.Perioperative electrolyte disorder mgt1.
Perioperative electrolyte disorder mgt1.
Kanbiro Gedeno
 
Fluid & electrolyte imbalance module.pdf
Fluid & electrolyte imbalance module.pdfFluid & electrolyte imbalance module.pdf
Fluid & electrolyte imbalance module.pdf
ABHIJIT BHOYAR
 
Fluid therapy in paediatrics
Fluid therapy in paediatricsFluid therapy in paediatrics
Fluid therapy in paediatricsAli Alsafi
 
Fluids and electrolytes balance
Fluids and electrolytes balanceFluids and electrolytes balance
Fluids and electrolytes balance
Jippy Jack
 
Fluid and electrolyt balance
Fluid and electrolyt balance Fluid and electrolyt balance
Fluid and electrolyt balance
shaikkhadeer6
 
Disorders of electrolyte and acid base balance
Disorders of electrolyte and acid base balance Disorders of electrolyte and acid base balance
Disorders of electrolyte and acid base balance
Tigreentertainment
 
Perioperative fluid therapy
Perioperative fluid therapyPerioperative fluid therapy
Perioperative fluid therapy
logon2kingofkings
 
Dr chandrashekar 2016 sodium disturbances
Dr chandrashekar 2016 sodium  disturbancesDr chandrashekar 2016 sodium  disturbances
Dr chandrashekar 2016 sodium disturbances
intentdoc
 
Fluids and Electrolytes
Fluids and ElectrolytesFluids and Electrolytes
Fluids and Electrolytes
Abhay Rajpoot
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytes
ekhlashosny
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytesekhlashosny
 
Body Fluid And Electrolyte Balance
Body Fluid And Electrolyte BalanceBody Fluid And Electrolyte Balance
Body Fluid And Electrolyte Balance
mvraveendrambbs
 

Similar to afghan med lec fluid.pptx (20)

Fluid Therapy in Pediatrics
Fluid Therapy in PediatricsFluid Therapy in Pediatrics
Fluid Therapy in Pediatrics
 
Fluid therapy
Fluid therapyFluid therapy
Fluid therapy
 
Postoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptxPostoperative fluid and electrolyte management.pptx
Postoperative fluid and electrolyte management.pptx
 
FLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptxFLUID AND ELECTROLYTES.pptx
FLUID AND ELECTROLYTES.pptx
 
Fluid and electrolyte balance
Fluid and electrolyte balanceFluid and electrolyte balance
Fluid and electrolyte balance
 
Fluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptxFluid Management Hooman Rowshan, M.D..pptx
Fluid Management Hooman Rowshan, M.D..pptx
 
electrolytes mbbs class 2024 new.pptx ppt
electrolytes mbbs class 2024 new.pptx pptelectrolytes mbbs class 2024 new.pptx ppt
electrolytes mbbs class 2024 new.pptx ppt
 
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptxFLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
FLUID_AND_ELECTROLYTE_MANAGEMENT_OF_THE.pptx
 
Perioperative electrolyte disorder mgt1.
Perioperative electrolyte disorder mgt1.Perioperative electrolyte disorder mgt1.
Perioperative electrolyte disorder mgt1.
 
Fluid & electrolyte imbalance module.pdf
Fluid & electrolyte imbalance module.pdfFluid & electrolyte imbalance module.pdf
Fluid & electrolyte imbalance module.pdf
 
Fluid therapy in paediatrics
Fluid therapy in paediatricsFluid therapy in paediatrics
Fluid therapy in paediatrics
 
Fluids and electrolytes balance
Fluids and electrolytes balanceFluids and electrolytes balance
Fluids and electrolytes balance
 
Fluid and electrolyt balance
Fluid and electrolyt balance Fluid and electrolyt balance
Fluid and electrolyt balance
 
Disorders of electrolyte and acid base balance
Disorders of electrolyte and acid base balance Disorders of electrolyte and acid base balance
Disorders of electrolyte and acid base balance
 
Perioperative fluid therapy
Perioperative fluid therapyPerioperative fluid therapy
Perioperative fluid therapy
 
Dr chandrashekar 2016 sodium disturbances
Dr chandrashekar 2016 sodium  disturbancesDr chandrashekar 2016 sodium  disturbances
Dr chandrashekar 2016 sodium disturbances
 
Fluids and Electrolytes
Fluids and ElectrolytesFluids and Electrolytes
Fluids and Electrolytes
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytes
 
Fluids & Electrolytes
Fluids & ElectrolytesFluids & Electrolytes
Fluids & Electrolytes
 
Body Fluid And Electrolyte Balance
Body Fluid And Electrolyte BalanceBody Fluid And Electrolyte Balance
Body Fluid And Electrolyte Balance
 

More from ayoubhasand1

045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt
ayoubhasand1
 
UGIB
UGIBUGIB
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajajgemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
ayoubhasand1
 
Birth asphyxia.ppt
Birth asphyxia.pptBirth asphyxia.ppt
Birth asphyxia.ppt
ayoubhasand1
 
Birth Trauma. Asphyxia.ppt
Birth Trauma. Asphyxia.pptBirth Trauma. Asphyxia.ppt
Birth Trauma. Asphyxia.ppt
ayoubhasand1
 
Weinberg-study-design-full-set.ppt
Weinberg-study-design-full-set.pptWeinberg-study-design-full-set.ppt
Weinberg-study-design-full-set.ppt
ayoubhasand1
 
hiv-aids (epidemiologyl).pptx
hiv-aids (epidemiologyl).pptxhiv-aids (epidemiologyl).pptx
hiv-aids (epidemiologyl).pptx
ayoubhasand1
 
COVID-19 Critical Care + ventilation.pptx
COVID-19 Critical Care + ventilation.pptxCOVID-19 Critical Care + ventilation.pptx
COVID-19 Critical Care + ventilation.pptx
ayoubhasand1
 
Gynae_Vaginal_Discharge.ppt
Gynae_Vaginal_Discharge.pptGynae_Vaginal_Discharge.ppt
Gynae_Vaginal_Discharge.ppt
ayoubhasand1
 

More from ayoubhasand1 (9)

045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt045_2_blood_transfusion_0.ppt
045_2_blood_transfusion_0.ppt
 
UGIB
UGIBUGIB
UGIB
 
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajajgemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
gemc-nursing-2012-perry-id_typhoid_fever_infectious_diarrhea-oer.pptgshajaj
 
Birth asphyxia.ppt
Birth asphyxia.pptBirth asphyxia.ppt
Birth asphyxia.ppt
 
Birth Trauma. Asphyxia.ppt
Birth Trauma. Asphyxia.pptBirth Trauma. Asphyxia.ppt
Birth Trauma. Asphyxia.ppt
 
Weinberg-study-design-full-set.ppt
Weinberg-study-design-full-set.pptWeinberg-study-design-full-set.ppt
Weinberg-study-design-full-set.ppt
 
hiv-aids (epidemiologyl).pptx
hiv-aids (epidemiologyl).pptxhiv-aids (epidemiologyl).pptx
hiv-aids (epidemiologyl).pptx
 
COVID-19 Critical Care + ventilation.pptx
COVID-19 Critical Care + ventilation.pptxCOVID-19 Critical Care + ventilation.pptx
COVID-19 Critical Care + ventilation.pptx
 
Gynae_Vaginal_Discharge.ppt
Gynae_Vaginal_Discharge.pptGynae_Vaginal_Discharge.ppt
Gynae_Vaginal_Discharge.ppt
 

Recently uploaded

Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 

Recently uploaded (20)

Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 

afghan med lec fluid.pptx

  • 1. Perioperative management and Fluid Neda Amini, MD Northwell health Surgical oncology Fellow
  • 2. BODY WATER DISTRIBUTION  Percent Of Body Weight –Male: 55 – 60% –Female: 50 – 55%  Fluid Compartments  intracellular volume : 2/3 of Body Water  extracellular volume: 1/3 of Body Water  Plasma: 25% of ECF  Interstitial Fluid: 75% of ECF
  • 3.
  • 4.  healthy 70-kg male predicted to have a TBW content of 42 L (60% of total body weight). The intracellular volume is 28 L (two-thirds TBW) and the extracellular volume 14 L (one-third TBW)>>3.5 L plasma  balance of TBW is directed by a complex interaction between membranes and solutes  Membranes separating intracellular and extracellular compartments are freely permeable to water, such that the osmolality of the intracellular, interstitial, and intravascular compartments remains equal.
  • 5. Albumin represents the most important osmotically active constituent of the ECV and is virtually excluded from the ICV. Albumin is unequally distributed within the ECV; the serum concentration of albumin approximates 4.0g/dl, while the IF concentration averages 1.0g/dl. Capillary membranes are freely permeable to most small solutes (less than 50,000 kDA), including sodium, potassium, glucose, and low-molecular-weight proteins. They have the ability to create osmotic forces that direct the movement of water across a membrane. Water moves across membranes via intercellular junctions or transcellular routes These nonpermeable solutes are known as effective osmoles.
  • 6.  Movement of water across capillary membranes is directed by competing forces known as Starling’s law.  Starling’s law states that net filtration is the difference between the hydrostatic and oncotic pressures of both the interstitial and the capillary fluids.
  • 7.  Although small solutes do not contribute to water movement across capillary membranes, they do function as effective osmoles that direct water movement between the intracellular and extracellular spaces across cell membranes.  Sodium (Na+) : potassium (K+) are the principal determinants of extracellular osmolarity  potassium (K+) are the principal determinants of intracellular osmolality  Na+ and K+ are unable to passively diffuse across the lipid-rich membrane with a gradient generated and maintained by the Na+/K+ adenosine triphosphatase (ATPase) pump mechanism.  Manipulation of either of these ions results in water movement from lower to higher osmolality compartment in order to reestablish equilibrium.
  • 8.  For example, administration of hypotonic solution (e.g., 0.45% NaCl solution) results in decreased extracellular osmolality, so water moves from the extracellular space to the intracellular space, resulting in cellular swelling.  In contrast, administration of a hypertonic solution (e.g., 3% NaCl solution) results in increased extracellular osmolality, so water moves from the intracellular space to the extracellular space, resulting in cellular dehydration.
  • 9. Serum Osmolality  Measure of solute (osmoles) per KG of water  –Only accounts for solute which contributes to the solution’s osmotic pressure  Serum Osmolality–Formula:(2 X [Na]) + [Glucose]/18 + [BUN]/2.8  Normal: 278 – 300 mOsm/kg
  • 10.  Elevations in plasma osmolality result in stimulation of thirst along with antidiuretic hormone (ADH) secretion from the posterior pituitary gland.  ADH release results in upregulation of aquaporin channels in the basolateral membrane of distal collecting tubules in the kidney, promoting free water resorption down an established gradient. As a result of increased aquaporin insertion, urine osmolality increases, with variations from 100 to 1200 mOsm/kg depending on the serum osmolality.  ADH secretion is also triggered by central baroreceptors that detect decreased plasma volume. The result of ADH secretion is free water reabsorption in the body’s attempt to restore normal osmolality and maintain homeostasis.
  • 11.  The renin-angiotensin-aldosterone (RAA) axis promotes volume expansion. Renin is secreted by the juxtaglomerular cells in response to renal hypoperfusion or low sodium concentration in the macula densa region of the distal tubule.  Renin secretion promotes formation of angiotensin from angiotensinogen and the eventual production of aldosterone, which promotes sodium reabsorption.  atrial natriuretic peptide (ANP) results in net diuresis. ANP is a systemic hormone released in response to cardiac atrial stretch and results in increased renal blood flow through dilation of the afferent glomerular arteriole and inhibition of sodium reabsorption in the kidney.
  • 12.
  • 13. Assessment of Fluid Status  In the immediate postoperative period, patients may have fluid deficits resulting from preoperative or intraoperative fluid losses. Continued fluid losses in the extended postoperative period from urine, skin, and the gastrointestinal (GI) tract are common.  It should be recognized that intravenous (IV) fluids are a therapy capable of providing benefit when utilized appropriately but also able to cause harm when used inappropriately.  Commonly seen in the postoperative period, inflammatory states result in a low effective intravascular volume despite an overall positive fluid balance due to cytokine-induced permeability, which increases extracellular volume.  Common signs and symptoms of low effective circulatory volume include abnormal mentation, excessive thirst, dry mucous membranes, poor skin turgor, tachycardia, hypotension, orthostatic changes in vital signs, and oliguria.
  • 14.  Daily weights  serum and urine electrolyte levels  acid-base balance  invasive monitoring  Urine output is an excellent measure of volume status; adults should produce at least 0.5 mL/kg/hr, whereas children should produce nearly 1 to 2 mL/kg/hr.  However, in the setting of renal insufficiency, those receiving diuretics, or those in hyperglycemic states, urine output may be an inaccurate measure of volume status and resuscitation.
  • 15. Additional indicators of intravascular depletion: elevated hematocrit low serum bicarbonate level with a base deficit blood urea nitrogen/creatinine ratio greater than 20:1 (prerenal azotemia) fractional excretion of sodium (FENa) of less than 1%.
  • 16.  Elevated urine osmolality may suggest intravascular hypovolemia, but in the setting of renal insufficiency or use of diuretics it is often an inaccurate measure. The equation for fractional excretion of sodium is as follows:
  • 17. Maintenance Fluids and Daily Electrolyte Requirements  Sensible losses can be quantified and occur primarily in urine (∼800 to 1500 mL daily) and stool (∼250 mL daily).  Insensible losses are unable to be quantified and include cutaneous losses from the skin (75%) and upper respiratory tract (25%). Insensible losses often are quantified roughly at 8 to 12 mL/kg per day.  Sensible and insensible losses vary greatly in different physiologic states and pathologic conditions, including fever, hyperventilation, burns, tachycardia, and other hypermetabolic states.  Cutaneous insensible losses increase by 10% per day for each 1°C increase in body temperature above 37.1°C. Laparotomy and thoracotomy increase insensible losses from the operative site at rates that approach nearly 1 L/hr.
  • 18.  Daily maintenance fluid administration in both pediatric and adult populations can be calculated for a 24-hour period utilizing the 100-50-20 rule or hourly utilizing the 4-2-1 rule  By definition, maintenance fluids contain dextrose. Their electrolyte composition is variable and allows for replacement of these lost from insensible and sensible losses but these levels should be closely monitored in postoperative patients.  In general, the most common postoperative maintenance fluid for adults consists of 5% dextrose in one-half normal saline (D5 1⁄2NS) with 20 mEq/L KCl. 
  • 19.  In children the standard maintenance fluid is D5 1⁄2NS or D5 lactated Ringer’s solution (LR). This is to avoid hyponatremia, which has been shown to be of critical importance in the pediatric population.  Children younger than 2 years usually receive D5 1⁄4NS, with 20 mEq/L. The reason for this is that until age 2 years, the kidney has a glomerular filtration rate (GFR) that is one-quarter the adult level, and the distal nephrons are unable to effectively concentrate the urine, leading to a difficulty in excreting high sodium loads.
  • 20.
  • 21.
  • 23.  When administering maintenance fluids, utilizing a 4-2-1 dosing regimen in a 70-kg male (110 mL/hr) results in a total sodium load of 203 mEq in a 24-hour period, which is greater than the required 1 to 2 mEq/kg/day.  Although patients with normal kidney function are able to excrete the excess sodium load, caution should be utilized in patients with underlying renal dysfunction, cardiac failure, or other serious comorbidities to not cause iatrogenic hypernatremia.  In general, maintenance fluids should be reassessed at least daily to ensure that correct electrolyte and fluid volume needs are met but not exceeded.
  • 24. Resuscitative Fluids  Resuscitative fluids are most commonly used the immediate postoperative period, after injury, and in the setting of hypotension.  The rate of fluid administration is determined by the severity of the existing deficit, presence of ongoing losses, and the patient’s comorbidities.  NS and LR closely approximate the composition of extracellular fluid and therefore are the most commonly used resuscitative fluids.  LR has a pH of 6.5 and provides 28 mEq of bicarbonate (HCO3 −) per liter, making it preferential in the setting of acidosis.  NS, at a pH of 4.5, does not contain HCO3 − but has a greater concentration of Na+ and Cl− (154 mEq), making it preferential in patients with a metabolic alkalosis.  However, it can create hyperchloremic metabolic acidosis in the setting of high volume resuscitation.
  • 25.  Severe fluid losses resulting in hemodynamic instability should be replaced with isotonic resuscitative fluid boluses of 0.9% sodium chloride (NS solution) or LR solution at volumes of 10 to 20 mL/kg, with boluses repeated until adequate resuscitation is reached.  Colloid solutions, such as 5% albumin, theoretically provide an advantage when restoring intravascular volume because of the oncotic pressure afforded by the protein content. However, liberal use of colloid solutions is less cost effective and has not demonstrated improved patient outcomes in randomized studies.
  • 26. Sydney Ringer, credited for the development of lactated Ringer solution. In 1883, Sydney Ringer reported influence exerted by the the blood on the contractions of ventricle
  • 27. Perioperative Care Management Domains  Smoking Cessation ▪ urge all patients to quit smoking prior to surgery  Smoking cessation intervention for all smokers, ideally ≥6 weeks before surgery
  • 28. Frailty  describe generalized poor functional status and reduced physiologic reserve that results in increased vulnerability to adverse outcomes.  Frailty should be evaluated before considering major elective surgery. Common clinical assessments include questionnaires such as the Modified Frailty Index (MFI) and Clinical Frailty Scale (CFS)  6-minute walking distance (6MWD) or hand-grip strength test.  Improvement in these objective measurements over time has been shown to improve outcomes.
  • 29. Nutritional Status  Balanced diet for all surgical patients  Preoperative screening for malnutrition to allow for referral to dietitian and immediate intervention if screening positive
  • 30. MEDICATION MANAGEMENT  Take morning of surgery:  b-Blocker  Asthmatic medications  GERD medications  Statins  Aspirin (for CV surgery)  ACE Inhibitors (if for Heart Failure & BP adequate)  Calcium Channel Blocker–Alpha 2 Agonists
  • 31. ORAL HYPOGLYCEMIC AGENTS  Hold the morning of surgery  Metformin Exception: Stop 24 hrs prior to procedures with contrast dye  Major Surgery: Reports of lactic acidosis (when taken postoperatively  Minor Surgery: No studies
  • 32. INSULIN  Hold morning dose of short/rapid-acting Insulin  Reduce long-acting agents by half when taken night prior  Assess blood glucose at hospital in AM
  • 33. ACE INHIBITORS  Discontinue night before surgery  Exception: CHF patients  Issues–Suppresses renin-angiotensin pathway–Hypotension unresponsive to normal pressorswith general anesthesia induction
  • 34. ANTICOAGULANTS  Discontinuation varies with drug–Warfarin: 5 days  Clopidogrel: 7 days  Enoxaparin: 12 – 24 hours
  • 35. Cardiac Stents  Elective Noncardiac Surgery–  Defer 12 months if possible  Can’t wait –BMS – 30 days  DES – 6 months–Discontinue clopidogrel 7 days prior–Continue Aspirin through perioperative period(except neurosurgery and retinal surgery)